TNFRSF1B Signaling Blockade Protects Airway Epithelial Cells from Oxidative Stress
Open Access
- 18 March 2024
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 13 (3) , 368
Abstract
Progressive respiratory airway destruction due to unresolved inflammation induced by periodic infectious exacerbation episodes is a hallmark of cystic fibrosis (CF) lung pathology. To clear bacteria, neutrophils release high amounts of reactive oxygen species (ROS), which inflict collateral damage to the neighboring epithelial cells causing oxidative stress. A former genome-wide small interfering RNA (siRNA) screening in CF submucosal gland cells, instrumental for mucociliary clearance, proposed tumor necrosis factor receptor superfamily member 1B (TNFRSF1B; TNFR2) as a potential hit involved in oxidative stress susceptibility. Here, we demonstrate the relevance of TNFRSF1B transcript knock-down for epithelial cell protection under strong oxidative stress conditions. Moreover, a blockade of TNFR signaling through its ligand lymphotoxin-α (LTA), overexpressed in airway epithelial cells under oxidative stress conditions, using the anti-tumor necrosis factor (TNF) biologic etanercept significantly increased the viability of these cells from a toxic oxidizing agent. Furthermore, bioinformatic analyses considering our previous RNA interference (RNAi) screening output highlight the relevance of TNFRSF1B and of other genes within the TNF pathway leading to epithelial cell death. Thus, the inhibition of the LTα3-TNFR2 axis could represent a useful therapeutic strategy to protect the respiratory airway epithelial lining from the oxidative stress challenge because of recurrent infection/inflammation cycles faced by CF patients.Keywords
Funding Information
- CERCA Programme/Generalitat de Catalunya (PI16/00377, PI20/00464, 2021SGR 00521)
- “Associació Catalana de Fibrosi Quística” (PI16/00377, PI20/00464, 2021SGR 00521)
- Instituto de Salud Carlos III (PI16/00377, PI20/00464, 2021SGR 00521)
- FEDER funds/European Regional Development Fund (ERDF) (PI16/00377, PI20/00464, 2021SGR 00521)
- Generalitat de Catalunya (PI16/00377, PI20/00464, 2021SGR 00521)
This publication has 35 references indexed in Scilit:
- Cystic fibrosisThe Lancet, 2021
- Mucus, mucins, and cystic fibrosisPediatric Pulmonology, 2019
- TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants – past, present and futureCytokine & Growth Factor Reviews, 2014
- Etanercept: A Review of Its Use in Autoimmune Inflammatory DiseasesDrugs, 2014
- Role of NADPH oxidase/ROS in pro-inflammatory mediators-induced airway and pulmonary diseasesBiochemical Pharmacology, 2012
- Improvements in Cystic Fibrosis Lung Disease and Airway Inflammation Associated with Etanercept Therapy for Rheumatoid Arthritis: A Case ReportLung, 2012
- Established cell lines used in cystic fibrosis researchJournal of Cystic Fibrosis, 2004
- The molecular architecture of the TNF superfamilyTrends in Biochemical Sciences, 2002
- TNF? and the TNF receptor superfamily: Structure-function relationship(s)Microscopy Research and Technique, 2000
- Apoptosis mediated by the TNF-related cytokine and receptor familiesJournal of Cellular Biochemistry, 1996